Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 16
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (866)
- Volume 16, 2024 (19)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 16, 2024
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Di Matteo S, Freilone R, Bruno GM, Notaro R, Moumene S, Martone N, Teruzzi C, Ciccarone A, Colombo GL
ClinicoEconomics and Outcomes Research 2024, 16:225-232
Published Date: 11 April 2024
Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model
Alshowair A, Altamimi S, Alruhaimi FA, Alshahrani S, Alsuwailem F, Alkhaldi M, Abdalla H, Alkhuraiji FH, Alaqeel MS, Almureef SS, Alhawasy S, Abdel-Azeem A
ClinicoEconomics and Outcomes Research 2024, 16:211-223
Published Date: 4 April 2024
Willingness to Pay for Social Health Insurance Among Health Care Professionals in North Wollo Zone, Amhara Region, Ethiopia: Mixed Method Study [Retraction]
Girmaw F, Adane E, Kassaw AT, Ashagrie G, Baye T
ClinicoEconomics and Outcomes Research 2024, 16:209-210
Published Date: 3 April 2024
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation
Kipp R, Herzog LO, Khanna R, Zhang D
ClinicoEconomics and Outcomes Research 2024, 16:197-208
Published Date: 27 March 2024
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach
Bagepally BS, Kumar S S, Sasidharan A
ClinicoEconomics and Outcomes Research 2024, 16:187-196
Published Date: 26 March 2024
Key Performance Indicators: A Framework for Allied Healthcare Educational Institutions
Sreedharan JK, Subbarayalu AV, Kamalasanan A, Albalawi I, Krishna GG, Alahmari AD, Alsalamah JA, Alkhathami MG, Alenezi M, Alqahtani AS, Alahmari M, Phillips MR, MacDonald J
ClinicoEconomics and Outcomes Research 2024, 16:173-185
Published Date: 26 March 2024
The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors
Al-Dwairi RA, Aleshawi A, Abu-zreig L, Al-Shorman W, Al Beiruti S, Alshami AO, Allouh MZ
ClinicoEconomics and Outcomes Research 2024, 16:161-171
Published Date: 15 March 2024
Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson’s Disease Psychosis
Rajagopalan K, Rashid N, Yakkala V, Doshi D
ClinicoEconomics and Outcomes Research 2024, 16:149-159
Published Date: 11 March 2024
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis
Yuen KC, Blevins LS, Clemmons DR, Faurby M, Hoffman AR, Kelepouris N, Kerr JM, Tarp JM, Fleseriu M
ClinicoEconomics and Outcomes Research 2024, 16:133-147
Published Date: 8 March 2024
The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis
Gogas Yavuz D, Akhtar O, Low K, Gras A, Gurser B, Yilmaz ES, Basse A
ClinicoEconomics and Outcomes Research 2024, 16:123-132
Published Date: 5 March 2024
The Economic Burden of the COVID-19 Pandemic in State of Kuwait
Nur AM, Aljunid SM, Almari M
ClinicoEconomics and Outcomes Research 2024, 16:111-122
Published Date: 4 March 2024
Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study
Johal S, Brannman L, Genestier V, Cawston H
ClinicoEconomics and Outcomes Research 2024, 16:97-109
Published Date: 28 February 2024
Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies
Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr
ClinicoEconomics and Outcomes Research 2024, 16:81-96
Published Date: 14 February 2024
Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening
Hoxha M, Malaj V, Zappacosta B, Firza N
ClinicoEconomics and Outcomes Research 2024, 16:69-80
Published Date: 9 February 2024
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study
Benedict RH, Vo P, Adlard N, Grennan O, Enstone A, Bridge D, Wyn R, Cohan SL
ClinicoEconomics and Outcomes Research 2024, 16:55-67
Published Date: 8 February 2024
Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review
Guertin JR, Gilbert-Ouimet M, Dugas M, Carnovale V, Jalbert L, Svyntozelska O, Demers J, Matteau L, Bergeron F, LeBlanc A
ClinicoEconomics and Outcomes Research 2024, 16:35-53
Published Date: 26 January 2024
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review
Aprilianti S, Utami AM, Suwantika AA, Zakiyah N, Azis VI
ClinicoEconomics and Outcomes Research 2024, 16:25-34
Published Date: 26 January 2024
Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective
Bassani R, Galvain T, Battaglia S, Maheswaran H, Wright G, Kambli A, Piemontese A
ClinicoEconomics and Outcomes Research 2024, 16:13-24
Published Date: 18 January 2024
Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)
Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL
ClinicoEconomics and Outcomes Research 2024, 16:1-12
Published Date: 12 January 2024